News-Medical.Net on MSN
Nirsevimab sharply cuts RSV hospitalizations in U.S. infants during the 2024–2025 season
In a nationwide EHR cohort of over 400,000 U.S. infants during the 2024–2025 RSV season, nirsevimab use was linked to a 77% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback